Comment on

• 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.

  Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, Hasselbalch S, Law I, Andersen A, Korner A, Minthon L, Garraux G, Nelissen N, Bormans G, Buckley C, Owenius R, Thurfjell L, Farrar G, Brooks DJ. Vandenberghe R, et al. Ann Neurol. 2010 Sep;68(3):319-29. doi: 10.1002/ana.22068. Ann Neurol. 2010. PMID: 20687209 Clinical Trial.